MDR1 causes resistance to the antitumour drug miltefosine

British Journal of Cancer

Volumn 84, Issue 10, 2001, Pages 1405-1411

  Rybczynska, M ^a   Liu, R ^b   Lu, P ^b   Sharom, F J ^b   Steinfels, E ^c   Pietro, A Di ^c   Spitaler, M ^a   Grunicke, H ^a   Hofmann, J ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF GUELPH   (Canada)

^c INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

Hexadecylphosphocholine; MDR1; Miltefosine; Multidrug resistance

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; COLCHICINE; DOXORUBICIN; GLYCOPROTEIN P; MILTEFOSINE; VERAPAMIL; VINBLASTINE;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RESISTANCE; CONCENTRATION RESPONSE; DRUG PROTEIN BINDING; DRUG SENSITIVITY; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; DRUG RESISTANCE, MULTIPLE; FEMALE; HELA CELLS; HUMANS; P-GLYCOPROTEIN; P-GLYCOPROTEINS; PHOSPHORYLCHOLINE; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035906850     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1776     Document Type: Article

References (43)

1. Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein
2. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs
3. Membrane-interactive lipids as experimental anticancer drugs
4. Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells
5. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters
6. An altered pattern of cross-resistance in multidrug resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene
7. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP-and steroid-binding sites on mouse P-glycoprotein
8. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells
9. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells
10. A multidrug resistance transporter from MCF-7 breast cancer cells
11. Bcl-2 plays a key role instead of mdr1 in the resistance to hexadecylphosphocholine in human epidermoid tumor cell line KB
12. The genetic origin of drug resistance in neoplasms: Implications for systemic therapy
13. Biochemistry of multidrug resistance mediated by the multidrug transporter
14. Alkylphosphocholines: A new class of membrane-active anticancer agents
15. Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro
16. Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440)
17. A new vector using the human multidrug resistance gene as a selectable marker enables overexpression of foreign genes in eukaryotic cells
18. Altered expression of the genes regulating apoptosis in multidrug resistant human myeloid leukemia cell lines overexpressing MDR1 or MRP gene
19. Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells
20. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene
21. Reduced permeability in CHO cells as a mechanism of resistance to colchicine
22. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains
23. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
24. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
25. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter
26. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
27. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185-Val-185 substitution in P-glycoprotein
28. The drug resistance-related protein LRP is the human major vault protein
29. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities
30. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone - Evidence for a third drug-binding site
31. The P-glycoprotein efflux pump: How does it transport drugs?
32. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein
33. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores
34. Synthetic hydrophobic peptides are substrate for P-glycoprotein and stimulate drug transport
35. Spectroscopic and biophysical approaches for studying the structure and function of the P-glycoprotein multidrug transporter
36. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: Peptide binding and effects on drug transport and accumulation
37. Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies
38. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
39. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis
40. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1
41. Multidrug resistance gene family and chemical carcinogenesis
42. Multidrug resistance in breast cancer: A meta-analysis of MDR1/Pgp170 expression and its possible functional significance
43. Identification of P-glycoprotein mutations causing a loss of steroid recognition and transport